Technologists 14 Years of Work; 5000 Traditional and Knowledge-based Products Made in Iran Got Production Licenses

In medicinal plants’ industry, one of the most strategic aims of Vice-presidency for Science and Technology, has been the completion of value chain in this industry.
Vice-presidency for Science and Technology established National Council for Science and Technology Development of Medicinal Plants and Traditional Medicine, in order to help develop the innovative ecosystem of medicinal plants’ industry. The council has succeeded to considerably elevate the technology of medicinal plants’ industry by purposeful services and support.
In medicinal plants’ industry, one of the most strategic aims of Vice-presidency for Science and Technology, has been the development of value chain in this industry. The chain which starts with research and development in cultivation Of medicinal plants and results in the export of medicinal plant-based products.
The value chain is a combination of activities which take place in an industry, like a chain which leads to value. According to the antecedent views, each company has a place in the value chain. Suppliers provide the inputs, the company adds value to the inputs, which then transfers them to the next agent until eventually they reach the customers. However, at the moment, in large corporations this chain is included in one big united collection.
The value chain of an industry is a simple, powerful and effective device, which defines position, power and distribution. Simply said, this chain is a plan of an industry with all its players, from producers of raw materials to retailers.
In case of a more developed value chain in medicinal plants’ industry, the creative, knowledge-based companies, researchers, medicinal plants farmers, providers, exporters and importers will all find their special place and work like members of a network.
Currently, over 1000 techological companies are active in value chain of medicinal plants and traditional medicine industry and, 186 of which are denominated as knowledge-based companies after being evaluated and their products and services approved.
Moreover, Food and Drug Administration has issued over 20 percent of its licenses for drugs and product manufacturing to the manufacturing of drugs and natural-based products.
Over 5000 drugs and natural-based products have received manufacturing licenses from Food and Drug Administration, contrary to 2008, when only 400 products received licenses from this organization.
According to Medicinal Plants and Traditional Medicine National Document, by 2025, the area under the cultivation of medicinal plants, must reach 500 thousand hectares.
With the endeavors of National Council for Science and Technology Development of Medicinal Plants and Traditional Medicine, the grounds and infrastructure for the establishment of value chain in the medicinal plants’ industry, have been prepared. There is hope for those active in this field to see value chain improving in this industry, with the support of the Council.